Stanley Sy, CEO and director of Sanomics, demonstrates an experiment at the Hong Kong Science Park in Sha Tin. Photo: Dickson Lee

Hong Kong could become a hub for genetics-based drugs discovery. Just one hitch – would Beijing stand in way?

  • Beijing bans export of human genetics data, citing national security concerns
  • Without mainland data, envisioned database would be of limited use

Topic |   Pharmaceuticals

TOP PICKS

Stanley Sy, CEO and director of Sanomics, demonstrates an experiment at the Hong Kong Science Park in Sha Tin. Photo: Dickson Lee
READ FULL ARTICLE